combination therapy with glp-1 receptor agonist and sglt2 inhibitor Blood pressure effects of inhibitors GLP‐1 agonists: Mechanisms, trial evidence and Real‐world data - Belančić - British Journal of Clinical Pharmacology A retrospective analysis of combination
Description
Rev Diabet Stud 10(23):110120 Bunck MC, Cornr A, Eliasson B, Heine RJ, Shaginian RM, Wu Y et al (2010) One-year treatment with exenatide vs
California Telehealth Regulations and Licensing Standards California enforces strict telehealth licensing requirements: clinicians must hold an active California medical or nurse practitioner license, conduct a reasonable medical evaluation before prescribing, and maintain appropriate patient records
GLP-1s have demonstrated anti-fibrotic properties in other organs (liver, kidney, heart) by reducing collagen deposition and tissue scarring (10)
In 1993, Nauck et al
Jastreboff 2023
